Lilac Pharma Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lilac Pharma Co., Ltd. - overview
Established
2016
Location
Sapporo, Hokkaido, Japan
Primary Industry
Pharmaceuticals
About
Based in Hokkaido, Japan, and founded in 2016, Lilac Pharma Co. , Ltd. , a. k.
a. Lilac Pharma, researchers and develops new formulations of nanoparticles, such as LNPs, liposomes, micelles, vesicles, emulsions, and more, that are used in pharmaceutical and cosmetic products. In January 2018, Lilac Pharma Co. , Ltd.
raised JPY 10 million in venture funding from the Hokkaido Research Institute for the Twenty-first Century and the North Pacific Bank. The company uses iLiNP microfluid technology, which helps in creating novel nanoparticle therapeutic materials for the cosmetics and pharmaceutical industries. Lilac Pharma also offers licensing and purchase of intellectual property rights services and focuses on research and consulting related to the research and development of pharmaceuticals, cosmetics, and more.
Current Investors
North Pacific Bank, Hokkaido Research Institute for the Twenty-first Century, Nippon Shokubai Co., LTD
Primary Industry
Pharmaceuticals
Sub Industries
Consulting Services, Intellectual Property, Pharmaceutical Research & Development
Website
www.lilacpharma.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.